Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States
暂无分享,去创建一个
Theresa L. Ford | J. Curtis | H. Yun | R. Dore | G. Kerr | Lang Chen | F. Xie | J. Kaine | G. Wright | S. Kennedy | Ilona Jileaeva | S. Dowell | M. Pedra-Nobre | S. Dolatabadi | Dianne Wollaston | Sawsan Najmey | Cynthia Lawrence Elliott | Heather North | Thaila Ramanujam | Stephanie Ott | Amina Richardson | I. Jileaeva
[1] Thomas J. Wang,et al. Geographic Inequalities in Cardiovascular Mortality in the United States: 1999 to 2018. , 2021, Mayo Clinic proceedings.
[2] R. Buchbinder,et al. Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis , 2020, The Journal of Rheumatology.
[3] J. Curtis,et al. Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry , 2020, The Journal of Rheumatology.
[4] J. Curtis,et al. Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available , 2020, Arthritis Research & Therapy.
[5] Patrick M. Wilson,et al. Neighborhood socioeconomic disadvantage is associated with multimorbidity in a geographically-defined community , 2020, BMC Public Health.
[6] O. Olopade,et al. Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis , 2019, JCO global oncology.
[7] M. Weinblatt,et al. Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study , 2020, Arthritis care & research.
[8] E. Kang,et al. Association between socioeconomic status and comorbidities among patients with rheumatoid arthritis: results of a nationwide cross-sectional survey. , 2019, Rheumatology.
[9] William R. Buckingham,et al. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. , 2018, The New England journal of medicine.
[10] E. Roughead,et al. The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System , 2018, BMJ Open.
[11] Li Wang,et al. Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs , 2018, Rheumatology advances in practice.
[12] A. Araujo,et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014 , 2017, Rheumatology International.
[13] J. Kremer,et al. The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights , 2017, Pharmacoepidemiology and drug safety.
[14] Brad Wright,et al. At Federally Funded Health Centers, Medicaid Expansion Was Associated With Improved Quality Of Care. , 2017, Health affairs.
[15] K. Liao,et al. Rheumatology Informatics System for Effectiveness: A National Informatics‐Enabled Registry for Quality Improvement , 2016, Arthritis care & research.
[16] S. Seabury,et al. Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis , 2016, Journal of managed care & specialty pharmacy.
[17] M. Hochberg,et al. Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events , 2015, Arthritis & rheumatology.
[18] Carmen DeNavas-Walt,et al. Income and Poverty in the United States: 2013 , 2014 .
[19] J. Kremer,et al. Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis. , 2013, The American journal of medicine.
[20] Jinoos Yazdany,et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice , 2012, Arthritis care & research.
[21] Stephen G. Martin,et al. Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study , 2012, Annals of the rheumatic diseases.
[22] D. Scott,et al. Co-morbidities in established rheumatoid arthritis. , 2011, Best practice & research. Clinical rheumatology.
[23] Christine Y. Lu,et al. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. , 2011, Journal of clinical epidemiology.
[24] D. Symmons,et al. Association of Functional Outcome With Both Personal- and Area-Level Socioeconomic Inequalities in Patients With Inflammatory Polyarthritis , 2009, Arthritis and rheumatism.
[25] T. Pincus,et al. RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories , 2008, The Journal of Rheumatology.
[26] F. Wolfe,et al. Comorbidities in rheumatoid arthritis. , 2007, Best practice & research. Clinical rheumatology.
[27] D. Labarthe,et al. Regional differences in African Americans' high risk for stroke: the remarkable burden of stroke for Southern African Americans. , 2007, Annals of epidemiology.
[28] J. Smolen,et al. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.
[29] Anne E Sales,et al. Construction and Characteristics of the RxRisk-V: A VA-Adapted Pharmacy-Based Case-mix Instrument , 2003, Medical care.
[30] Anne E Sales,et al. Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population , 2003, Medical care.
[31] J. Sundquist,et al. Cardiovascular risk factors and the neighbourhood environment: a multilevel analysis. , 1999, International journal of epidemiology.
[32] D. Commerce. Statistical abstract of the United States , 1978 .